SEC Tracker
Get the app

Biovie BIVI

Biovie announces $4.74 million offering

Item 1.01 Enters material agreement, Item 3.02 Unregistered share sale, Item 7.01 Investor disclosure

Form
8-K
Filed
Importance
Major
  1. Issued 960,000 shares of Class A common stock at $1.60 per share
  2. Issued 2,002,500 pre-funded warrants at $1.5999 per warrant
  3. Raised $4.74 million before fees and expenses
  4. Used proceeds for working capital and general corporate purposes

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Biovie files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. GT Biopharma GTBP public float $9M, Jun 30, 2025
  2. Talphera TLPH public float $8M, Jun 30, 2025
  3. Processa Pharmaceuticals PCSA public float $8M, Jun 30, 2025
  4. TherapeuticsMD TXMD public float $9M, Jun 30, 2025
  5. Oncotelic Therapeutics OTLC public float $9M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.